FDA Data Integrity Guidance: Applying Risk-Based Approaches Across Systems
FDA Data Integrity Guidance: Applying Risk-Based Approaches Across Systems Implementing FDA Data Integrity Guidance Through Risk-Based System Prioritisation Data integrity remains a cornerstone of pharmaceutical quality systems globally, underpinning patient safety, product efficacy, and regulatory compliance. The FDA data integrity guidance issued in recent years emphasizes a risk-based approach to managing data through manufacturing, laboratory,…
Read More “FDA Data Integrity Guidance: Applying Risk-Based Approaches Across Systems” »